Compare TMDX & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMDX | MLCO |
|---|---|---|
| Founded | 1998 | 2003 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.2B |
| IPO Year | 2019 | 2006 |
| Metric | TMDX | MLCO |
|---|---|---|
| Price | $78.56 | $5.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $148.22 | $10.10 |
| AVG Volume (30 Days) | 1.1M | ★ 2.2M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 382.18 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $605,494,000.00 | N/A |
| Revenue This Year | $24.25 | $5.42 |
| Revenue Next Year | $18.75 | $4.37 |
| P/E Ratio | $394.55 | ★ $12.16 |
| Revenue Growth | ★ 37.13 | N/A |
| 52 Week Low | $60.11 | $5.19 |
| 52 Week High | $156.00 | $10.15 |
| Indicator | TMDX | MLCO |
|---|---|---|
| Relative Strength Index (RSI) | 56.11 | 48.00 |
| Support Level | $64.90 | $5.33 |
| Resistance Level | $120.60 | $5.71 |
| Average True Range (ATR) | 4.22 | 0.22 |
| MACD | 1.88 | -0.02 |
| Stochastic Oscillator | 87.80 | 25.53 |
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs' electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 84% from Macao, with the rest from overseas as of 2025.